← All Signals

🏥 FDA: K.C. Pharmaceuticals, Inc — Class II

healthcareactionableSource: FDA
95%Confidence
0Views
FDASource
2026-04-17Date

Summary

Sterility concerns for K.C. Pharmaceuticals' tetrahydrozoline eye drops distributed through Perrigo and Walgreens further demonstrate widespread manufacturing quality failures. This affects major retail chains and increases regulatory exposure for all involved companies.

Actionable: Coordinate with Walgreens and Perrigo to remove affected products from shelves and implement emergency quality controls.

AI Confidence: 95%

Data Points

firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productSterile Eye Drops ORIGINAL FORMULA (tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15mL) bottles; a) Good Sense Sterile Eye Drops, Distributed By: Perrigo Di

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now